Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-24
2006-01-24
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S232800, C514S288000, C514S253030, C546S099000, C546S100000, C544S126000, C544S060000, C544S361000
Reexamination Certificate
active
06989390
ABSTRACT:
Disclosed is a salt of amonafide or amonafide analogs represented Structural Formula (I):R1 is —(CH2)nN+HR3R4 X−or R1 is —(CH2)nN+HR3R4 X−or —(CH2)nNR3R4 when R2 is —N+HR6R7.R2 is —OR5, halogen, —NR6R7, —N+HR6R7 X−′ sulphonic acid, nitro, —NR5COOR5, —NR5COR5 or —OCOR5;R3 and R4 are independently H, C1-C4 alkyl group or, taken together with the nitrogen atom to which they are bonded, a non-aromatic nitrogen-containing heterocyclic group;each R5 is independently —H or a C1-C4 alkyl group;R6 and R7 are independently H, C1-C4 alkyl group or, taken together with the nitrogen atom to which they are bonded, a non-aromatic nitrogen-containing heterocyclic group;n is an integer from 0-3; andX−is the carboxylate anion of an organic carboxylic acid compound.Also disclosed are methods of preparing certain compounds represented by Structural Formula (I).
REFERENCES:
patent: 4204063 (1980-05-01), Brana et al.
patent: 4614820 (1986-09-01), Zee-Cheng et al.
patent: 4665071 (1987-05-01), Zee-Cheng et al.
patent: 5183821 (1993-02-01), Brana et al.
patent: 5292881 (1994-03-01), Berneth et al.
patent: 5420137 (1995-05-01), Brana et al.
patent: 6693198 (2004-02-01), Ajami et al.
patent: 2002/0025916 (2002-02-01), Brown
patent: 2004/0132763 (2004-07-01), Ajami et al.
patent: 2323555 (1974-08-01), None
patent: 2323555 (1974-08-01), None
patent: 533.542 (1938-09-01), None
patent: 533.542 (1983-09-01), None
patent: WO 01/78705 (2001-10-01), None
Berge et al. Journal of Pharmaceutical Sciences, 1977, 66(1); 1-19.
Braña, Miguel Fernández, and Sanz, Antonio Martínez, “Synthesis and Cytostatic Activity of Benx(de)iso-quinolin-1, 3-Diones. Structure-Activity Relationships,”Eur. J. Med. Chem.-Chimica Therapeutica 16(3): 207-212 (1981).
Braña, F.M., “Mitonafide and Amonafide,”Ars. Pharmaceutica 36(3):377-415 (1995).
Braña, Miguel Fernández, and Sanz, Antonio Martinez, “Synthesis and Cytostatic Activity of Benz(de)iso-quinolin-1, 3-Diones. Structure-Activity Relationships,”Eur. J. Med. Chem.-Chimica Therapeutica16(3): 207-212 (1981).
Braña, F.M., “Mitonafide and Amonafide,”Ars. Pharmaceutica36(3): 377-415 (1995).
Ajami Alfred M.
Barlow David O.
Hamilton Brook Smith & Reynolds P.C.
Huang Evelyn Mei
Xanthus Life Sciences, Inc.
LandOfFree
Amonafide salts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amonafide salts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amonafide salts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3535385